# Novartis Pharmaceuticals A. G. – FDA Inspection, Mar 23, 2017

Source: https://www.keypedia.com/records/fda_inspections/novartis-pharmaceuticals-a-g/e00ca04c-fa6a-4cd3-be80-cea0ec862f62
Source feed: FDA_Inspections

> FDA inspection 1009385 of Novartis Pharmaceuticals A. G., March 23, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR parts 211 and 314. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009385
- Company Name: Novartis Pharmaceuticals A. G.
- Inspection Date: 2017-03-23
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- Issuing Officer
- [FDA Associated Person](https://www.keypedia.com/people/tenzin-jangchup/733eb315-0eeb-40ce-af6d-03b406a9235d)

Company: https://www.keypedia.com/companies/novartis-pharmaceuticals-a-g/b2132cf4-c297-41c1-a339-73dc2dea8f65

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c